Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2018
At a glance
- Drugs Corticotropin (Primary)
- Indications Vasculitis
- Focus Therapeutic Use
- 22 Aug 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.
- 22 Aug 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
- 22 Aug 2018 Status changed from recruiting to active, no longer recruiting.